VISEN Pharmaceuticals 維昇藥業

Please note that due to the planned shutdown of Webb-site.com, the directors, officers and advisers of HK-listed companies have ceased to be updated effective 2025-03-31. Appointments and resignations effective on or before that date were recorded, as were advisers recorded in annual reports filed on or before that date. A repository of our database and software is now available.
Snapshot date:
exclude unknown removal dates

Main board

Name Age
in
2025
Position From Until
1 Cao, Yibo 曹弋博 M 42 NEDNon-Executive Director 2021-01-08
2 Chan, Peng Kuan 陳炳鈞 M 62 INEDIndependent Non-Executive Director 2021-04-01
3 Chang, Michael J M 42 NEDNon-Executive Director 2023-12-01
4 Dong, Dandan (1984) 董丹丹 F 41 EDExecutive Director 2018-11-07 2023-12-13
5 Fu, Shan 付山 M 57 NEDNon-Executive Director 2018-11-01
6 Jensen, Michael Wolff M 54 NED, ChNon-Executive Director, Chairman 2021-01-08
7 Lu, Anbang 盧安邦 M 58 CEOChief Executive Officer 2018-11-07
8 Mikkelsen, Jan Møller M 66 NEDNon-Executive Director 2018-11-07
9 Ni, Hope Hong 倪虹 F 53 INEDIndependent Non-Executive Director 2021-04-01
10 Yao, Zhengbin M 59 INEDIndependent Non-Executive Director 2021-04-01

Manager/adviser/other

Name Age
in
2025
Position From Until
1 Chan, Sze Ting (Tricor) 陳詩婷 F 44 CoSecCompany Secretary 2025-03-08

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top